awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55363919-1CEF497E-BB2F-4A0E-8B2D-04A8F7FDC5F2
Q55363919-1CEF497E-BB2F-4A0E-8B2D-04A8F7FDC5F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55363919-1CEF497E-BB2F-4A0E-8B2D-04A8F7FDC5F2
Sym004-induced EGFR elimination is associated with profound anti-tumor activity in EGFRvIII patient-derived glioblastoma models.
P2860
Q55363919-1CEF497E-BB2F-4A0E-8B2D-04A8F7FDC5F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55363919-1CEF497E-BB2F-4A0E-8B2D-04A8F7FDC5F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae900082508f38d01fd34984d4e30a9acb36ada4
P2860
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma.